RPA3 and breast carcinoma: In the whole cohort, low cytoplasmic RPA3 protein was associated with poor breast cancer-specific survival (BCSS) (P = 0.0004) (Supplementary Fig. 7A) and DMFS (Supplementary Fig. 7B).